Sunrest Lifescie, a company in the Pharmaceuticals industry, reported revenue of ₹32 crore and net profit of ₹0.94 crore for the September 2026 quarter.
Sunrest Lifescie (NSE: SUN-RE-ST) closed at ₹36.00. Its market capitalisation is ₹15 crore and it trades at 5.5 times earnings.
Incorporated in 2017, Sunrest Lifescience Ltd trades in Health care and Cosmetics products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.